Ahmed glaucoma valve via pars plana access: Long-term results of implantation for therapy refractive glaucoma; [Ahmed Glaucoma Valve über Pars-plana-Zugang: Langzeitergebnisse von Implantationen bei therapierefraktärem Glaukom]

被引：0
作者：
Mazinani B. [1 ]
Schwarzer H. [1 ]
Willkomm A. [1 ]
Weinberger A. [1 ]
Plange N. [1 ]
Walter P. [1 ]
Rössler G. [1 ]
机构：
[1] Universitätsaugenklinik Aachen, 52074 Aachen
来源：
Der Ophthalmologe | 2013年 / 110卷 / 6期
关键词：
Glaucoma; Glaucoma drainage implants; Neovascular glaucoma; Uncompensated glaucoma; Vitrectomy;
D O I：
10.1007/s00347-012-2685-x
中图分类号：
学科分类号：
摘要：
Background: Aim of this study is the presentation of long-term results regarding the effectiveness and safety of the implantation of Ahmed glaucoma valve (AGV) devices using a pars plana approach after vitrectomy in the treatment of therapy refractive glaucoma. Methods: The implantation of AGV devices using a pars plana approach after vitrectomy was performed in 27 eyes of 22 patients with neovascular glaucoma (n = 7 patients), uveitis (n = 6), complex juvenile secondary glaucoma (n = 4), primary open angle glaucoma (n = 3), pseudoexfoliation glaucoma (n = 1) and nanophthalmus (n = 1). Intraocular pressure, visual acuity and subsequent complications were documented. The mean follow-up period was 23.6 months. Results: Intraocular pressure was significantly reduced from 30.2 mmHg preoperatively to 13 mmHg after a follow-up of 36 months. The mean visual acuity did not change significantly, five eyes required a subsequent explantation of which three were due to AGV-related complications. Conclusions: The implantation of AGV devices using a pars plana approach permits an effective and permanent reduction of intraocular pressure (IOP) even in severe therapy refractive secondary glaucoma; however, the risk of serious sight-threatening complications has to be taken into account. © 2012 Springer-Verlag Berlin Heidelberg.
引用
收藏
页码：537 / 542
页数：5
相关论文
共 21 条
  • [1] Alvarado J.A., Hollander D.A., Juster R.P., Lee L.C., Ahmed valve implantation with adjunctive mitomycin C and 5-fluorouracil: long-term outcomes, Am J Ophthalmol, 146, 2, pp. 276-284, (2008)
  • [2] Ayyala R.S., Zurakowski D., Smith J.A., Et al., A clinical study of the Ahmed glaucoma valve implant in advanced glaucoma, Ophthalmology, 105, 10, pp. 1968-1976, (1998)
  • [3] Budenz D.L., Barton K., Feuer W.J., Et al., Treatment outcomes in the Ahmed Baerveldt Comparison Study after 1 year of follow-up, Ophthalmology, 118, 3, pp. 443-452, (2011)
  • [4] Christakis P.G., Kalenak J.W., Zurakowski D., Et al., The Ahmed Versus Baerveldt Study: one-year treatment outcomes, Ophthalmology, 118, 11, pp. 2180-2189, (2011)
  • [5] Dada T., Bhartiya S., Vanathi M., Panda A., Pars plana Ahmed glaucoma valve implantation with triamcinolone-assisted vitrectomy in refractory glaucomas, Indian J Ophthalmol, 58, 5, pp. 440-442, (2010)
  • [6] Diaz-Llopis M., Salom D., Garcia-Delpech S., Et al., Efficacy and safety of the pars plana clip in the Ahmed valve device inserted via the pars plana in patients with refractory glaucoma, Clin Ophthalmol, 4, pp. 411-416, (2010)
  • [7] Eisenberg D.L., Koo E.Y., Hafner G., Schuman J.S., In vitro flow properties of glaucoma implant devices, Ophthalmic Surg Lasers, 30, 8, pp. 662-667, (1999)
  • [8] Hille K., Hille A., Ruprecht K.W., Drainage systems in glaucoma surgery, Ophthalmologe, 99, 12, pp. 902-916, (2002)
  • [9] Huang M.C., Netland P.A., Coleman A.L., Et al., Intermediate-term clinical experience with the Ahmed glaucoma valve implant, Am J Ophthalmol, 127, 1, pp. 27-33, (1999)
  • [10] Ishida K., Ahmed I.I., Netland P.A., Ahmed glaucoma valve surgical outcomes in eyes with and without silicone oil endotamponade, J Glaucoma, 18, 4, pp. 325-330, (2009)
123